ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

122 hedge funds and large institutions have $154M invested in Arbutus Biopharma in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 19 closing their positions.

Holders
122
Holders Change
+23
Holders Change %
+23.23%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
43
Increased
38
Reduced
22
Closed
19
Calls
$14.4M
Puts
$9.51M
Net Calls
+$4.92M
Net Calls Change
-$893K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$11.8M
2
BC
2
Brookfield Corp
Ontario, Canada
$4.64M
3
Nuveen Asset Management
3
Nuveen Asset Management
Illinois
$7.89M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$17.7M
5
GPP
5
Great Point Partners
Connecticut
$2.6M

Top Sellers

1
RI
1
RTW Investments
New York
$9.74M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
SG Americas Securities
3
SG Americas Securities
New York
$84K
4
WP
4
Woodline Partners
California
$0
5
Marshall Wace
5
Marshall Wace
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ECM
126
ExodusPoint Capital Management
New York
– -$95K -22,184 Closed
HighTower Advisors
127
HighTower Advisors
Illinois
– -$82K -19,065 Closed
HF
128
HRT Financial
New York
– -$80K -18,724 Closed
MAM
129
Meeder Asset Management
Ohio
– -$70K -16,499 Closed
LPL Financial
130
LPL Financial
California
– -$45K -10,600 Closed
PCM
131
Penserra Capital Management
California
– -$9K -2,265 Closed
AWA
132
Arkadios Wealth Advisors
Georgia
– -$4K -1,000 Closed
JWA
133
JFS Wealth Advisors
Pennsylvania
– -$4K -1,000 Closed
HI
134
Harbour Investments
Wisconsin
– -$3K -700 Closed
Federated Hermes
135
Federated Hermes
Pennsylvania
– -$3K -619 Closed
NFG
136
Next Financial Group
Texas
– -$1K -200 Closed
2 3 4 5
6